BCL2 and Hyperglycemia: Furthermore, the finding that FOXD1 plays a vital role in hyperglycaemia-induced renal and retinal injury implies the therapeutic potential of targeting the FOXD1-BCL-2 axis to attenuate the progression of T2DM.